141 related articles for article (PubMed ID: 21384091)
1. Apraclonidine and my pupil.
Cambron M; Maertens H; Crevits L
Clin Auton Res; 2011 Oct; 21(5):347-51. PubMed ID: 21384091
[TBL] [Abstract][Full Text] [Related]
2. Pupillometry study of brimonidine tartrate 0.2% and apraclonidine 0.5%.
Besada E; Reed K; Najman P; Shechtman D; Hardigan P
J Clin Pharmacol; 2011 Dec; 51(12):1690-5. PubMed ID: 21406599
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of digital pupillometry for diagnosis of Horner syndrome.
Yoo YJ; Yang HK; Hwang JM
PLoS One; 2017; 12(6):e0178361. PubMed ID: 28575101
[TBL] [Abstract][Full Text] [Related]
4. Congenital Horner's syndrome and the usefulness of the apraclonidine test in its diagnosis.
Mirzai H; Baser EF
Indian J Ophthalmol; 2006 Sep; 54(3):197-9. PubMed ID: 16921219
[TBL] [Abstract][Full Text] [Related]
5. Ocular effects of apraclonidine in Horner syndrome.
Morales J; Brown SM; Abdul-Rahim AS; Crosson CE
Arch Ophthalmol; 2000 Jul; 118(7):951-4. PubMed ID: 10900109
[TBL] [Abstract][Full Text] [Related]
6. False negative apraclonidine test in two patients with Horner syndrome.
Kawasaki A; Borruat FX
Klin Monbl Augenheilkd; 2008 May; 225(5):520-2. PubMed ID: 18454417
[TBL] [Abstract][Full Text] [Related]
7. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal cats.
Miller PE; Rhaesa SL
Am J Vet Res; 1996 Jan; 57(1):83-6. PubMed ID: 8720244
[TBL] [Abstract][Full Text] [Related]
8. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
Miller PE; Nelson MJ; Rhaesa SL
Am J Vet Res; 1996 Jan; 57(1):79-82. PubMed ID: 8720243
[TBL] [Abstract][Full Text] [Related]
9. Topical apraclonidine testing discloses pupillary sympathetic denervation in diabetic patients.
Koc F; Kansu T; Kavuncu S; Firat E
J Neuroophthalmol; 2006 Mar; 26(1):25-9. PubMed ID: 16518162
[TBL] [Abstract][Full Text] [Related]
10. A pharmacologic pupillary test in the diagnosis of diabetic autonomic neuropathy.
Kwon HJ; Kim HY
Korean J Ophthalmol; 2009 Dec; 23(4):291-5. PubMed ID: 20046691
[TBL] [Abstract][Full Text] [Related]
11. The role of apraclonidine in Horner’s syndrome – A case report.
Karadžić J; Kovačević I; Ljikar J
Srp Arh Celok Lek; 2016; 144(5-6):312-4. PubMed ID: 29648752
[TBL] [Abstract][Full Text] [Related]
12. Apraclonidine protection of the blood-aqueous barrier from traumatic break-down.
Bonomi L; Bellucci R; Pagliarusco A; Stefani L
J Ocul Pharmacol Ther; 1995; 11(1):25-35. PubMed ID: 8535954
[TBL] [Abstract][Full Text] [Related]
13. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy.
Yuen NS; Cheung P; Hui SP
Jpn J Ophthalmol; 2005; 49(2):89-92. PubMed ID: 15838723
[TBL] [Abstract][Full Text] [Related]
14. Impact of T3 thoracoscopic sympathectomy on pupillary function: a cause of partial Horner's syndrome?
Ramos R; Ureña A; Rivas F; Macia I; Rosado G; Pequeño S; Masuet C; Badia M; Miguel M; Delgado MA; Escobar I; Moya J
Surg Endosc; 2012 Apr; 26(4):1146-52. PubMed ID: 22044979
[TBL] [Abstract][Full Text] [Related]
15. Apraclonidine in the treatment of ptosis.
Wijemanne S; Vijayakumar D; Jankovic J
J Neurol Sci; 2017 May; 376():129-132. PubMed ID: 28431598
[TBL] [Abstract][Full Text] [Related]
16. Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma.
Nishimoto JH; Chang FW; Tang IH; Kolin T
J Am Optom Assoc; 1999 Apr; 70(4):233-9. PubMed ID: 10457699
[TBL] [Abstract][Full Text] [Related]
17. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.
Koc F; Kavuncu S; Kansu T; Acaroglu G; Firat E
Br J Ophthalmol; 2005 Nov; 89(11):1442-4. PubMed ID: 16234449
[TBL] [Abstract][Full Text] [Related]
18. Topical apraclonidine in the diagnosis of suspected Horner syndrome.
Freedman KA; Brown SM
J Neuroophthalmol; 2005 Jun; 25(2):83-5. PubMed ID: 15937427
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination.
Chen PL; Hsiao CH; Chen JT; Lu DW; Chen WY
Am J Ophthalmol; 2006 Sep; 142(3):469-74. PubMed ID: 16935593
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of patient demographics, etiologies and apraclonidine test results in adult Horner's syndrome.
Top Karti D; Karti O; Saruhan Durmaz G; Gokcay F; Celebisoy N
Int Ophthalmol; 2022 Apr; 42(4):1233-1239. PubMed ID: 34718919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
